Natural Product: NPC20050

Natural Product IDNPC20050
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
2Beta,3Beta-Epoxy-5,7,3',4'-Tetrahydroxyflavan-(4Alpha->8)-Epicatechin
IUPAC Name (2R,3R)-8-[(1aR,7S,7aS)-1a-(3,4-dihydroxyphenyl)-4,6-dihydroxy-7,7a-dihydrooxireno[2,3-b]chromen-7-yl]-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL3120540
PubChem CID 76325280
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001586] Biflavonoids and polyflavonoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey MSVVDBMAVSBGAQ-OUECKCITSA-N
Standard InCHI InChI=1S/C30H24O12/c31-13-7-20(37)24-23(8-13)41-30(12-2-4-16(33)19(36)6-12)29(42-30)26(24)25-21(38)10-17(34)14-9-22(39)27(40-28(14)25)11-1-3-15(32)18(35)5-11/h1-8,10,22,26-27,29,31-39H,9H2/t22-,26+,27-,29+,30+/m1/s1
SMILES c1cc(c(cc1[C@@H]1[C@@H](Cc2c(cc(c([C@@H]3c4c(cc(cc4O[C@]4(c5ccc(c(c5)O)O)[C@H]3O4)O)O)c2O1)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   576.13 Volume:   541.386
?
Van der Waals volume.
Dense:   1.064 LogP:   1.771
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.969
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.951
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   3.0 Rigid Bonds:   36.0
TPSA:   213.06
?
Topological Polar Surface Area.
H-Bond Acceptor:   12.0
H-Bond Donor:   9.0 Rings:   7.0
Heavy Atoms:   12.0

MedChem Properties

QED Drug-Likeness Score:   0.127 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.75 Fsp3:   0.2
MCE-18:   143.333
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.895 Fluc inhibitor:   0.289
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.64
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.73
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.488 Promiscuous compounds:   0.163

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.967 MDCK Permeability:   -4.805
Pgp-inhibitor:   0.0 Pgp-substrate:   0.156
PAMPA:   0.159
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.001
20% Bioavailability (F20%):   0.998 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.014 MRP1:   0.968
Plasma Protein Binding (PPB):   90.331% Volume Distribution (VD):   0.04
Fu: 15.376%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.995
OATP1B3 inhibitor:   0.995 BCRP inhibitor:   0.105
BSEP inhibitor:   0.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.996 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.164 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.066
CYP3A4-inhibitor:   0.001 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.492
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  6.336 Half-life (T1/2):  3.908

ADMET: Toxicity

hERG Blockers:  0.128 hERG Blockers (10um):  0.881
Human Hepatotoxicity (H-HT):  0.85 Drug-induced Liver Injury (DILI):  0.822
AMES Toxicity:  0.631 Rat Oral Acute Toxicity:  0.819
Maximum Recommended Daily Dose:  0.988 Skin Sensitization:  1.0
Carcinogencity:  0.028 Eye Corrosion:  0.0
Eye Irritation:  0.815 Respiratory Toxicity:  0.918
Drug-induced Neurotoxicity:  0.004 Ototoxicity:  0.954
Hematotoxicity:  0.022 Drug-induced Nephrotoxicity:  0.104
Genotoxicity:  0.998 RPMI-8226 Immunitoxicity:  0.067
A549 Cytotoxicity:  0.996 Hek293 Cytotoxicity:  0.972
BCF:   1.411
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.861
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.311
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.548
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO28679 Prunus mume Species Rosaceae Eukaryota flowers n.a. n.a. PMID[12193020]
NPO28679 Prunus mume Species Rosaceae Eukaryota fruits n.a. n.a. PMID[24485782]
NPO28679 Prunus mume Species Rosaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO28679 Prunus mume Species Rosaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28679 Prunus mume Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28679 Prunus mume Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO28679 Prunus mume Species Rosaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO28679 Prunus mume Species Rosaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT4416 Individual protein Tartrate-resistant acid phosphatase type 5 Mus musculus Inhibition = 106.67 % PMID[19942326]
NPT4416 Individual protein Tartrate-resistant acid phosphatase type 5 Mus musculus Inhibition = 216.77 % PMID[25495797]
NPT4416 Individual protein Tartrate-resistant acid phosphatase type 5 Mus musculus Inhibition = 97.95 % PMID[21130542]
NPT4416 Individual protein Tartrate-resistant acid phosphatase type 5 Mus musculus Inhibition = 199.06 % PMID[19124662]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 109.85 % PMID[24485782]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 185.08 % PMID[24485782]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 103.38 % PMID[24485782]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 240.74 % PMID[24485782]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 34.72 uM PMID[24485782]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Activity = 5.22 uM PMID[24485782]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC20050 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9265 High Similarity NPC306267
0.6667 Remote Similarity NPC58190
0.6667 Remote Similarity NPC108811
0.6667 Remote Similarity NPC170103
0.6667 Remote Similarity NPC236202
0.6667 Remote Similarity NPC262911
0.6667 Remote Similarity NPC202742
0.6575 Remote Similarity NPC246202
0.6575 Remote Similarity NPC224161
0.6575 Remote Similarity NPC46335
0.6575 Remote Similarity NPC279406
0.6575 Remote Similarity NPC486519
0.65 Remote Similarity NPC135021
0.6494 Remote Similarity NPC272552
0.6494 Remote Similarity NPC226108
0.6494 Remote Similarity NPC322899
0.6463 Remote Similarity NPC147743
0.6463 Remote Similarity NPC4809
0.6463 Remote Similarity NPC73517
0.641 Remote Similarity NPC302549
0.6235 Remote Similarity NPC106601
0.6235 Remote Similarity NPC151474
0.6203 Remote Similarity NPC46283
0.6203 Remote Similarity NPC469944
0.6203 Remote Similarity NPC278548
0.6173 Remote Similarity NPC478616
0.6173 Remote Similarity NPC478339
0.6163 Remote Similarity NPC212614
0.6163 Remote Similarity NPC205613
0.6125 Remote Similarity NPC44192
0.6118 Remote Similarity NPC86630
0.6 Remote Similarity NPC134911
0.5974 Remote Similarity NPC313116
0.5974 Remote Similarity NPC603340
0.5955 Remote Similarity NPC159526
0.5934 Remote Similarity NPC185231
0.5862 Remote Similarity NPC78074
0.5823 Remote Similarity NPC70409
0.5823 Remote Similarity NPC204770
0.5823 Remote Similarity NPC600551
0.5823 Remote Similarity NPC601980
0.5823 Remote Similarity NPC602065
0.5823 Remote Similarity NPC611024
0.5735 Remote Similarity NPC261619
0.5735 Remote Similarity NPC61477
0.5735 Remote Similarity NPC78770
0.5735 Remote Similarity NPC219876
0.5735 Remote Similarity NPC126029
0.5735 Remote Similarity NPC15658
0.5679 Remote Similarity NPC600630
0.5679 Remote Similarity NPC607896
0.5679 Remote Similarity NPC611369
0.5647 Remote Similarity NPC471404
0.5641 Remote Similarity NPC184245
0.5641 Remote Similarity NPC187801
0.5641 Remote Similarity NPC610920
0.5618 Remote Similarity NPC478337
0.5618 Remote Similarity NPC478338
0.5584 Remote Similarity NPC277331
0.5584 Remote Similarity NPC100482
0.5556 Remote Similarity NPC226809
0.5526 Remote Similarity NPC96576
0.5513 Remote Similarity NPC294558
0.5513 Remote Similarity NPC18185
0.5513 Remote Similarity NPC263940
0.5506 Remote Similarity NPC478340
0.55 Remote Similarity NPC155564
0.5484 Remote Similarity NPC478617
0.5366 Remote Similarity NPC211561
0.519 Remote Similarity NPC601999
0.5181 Remote Similarity NPC601997
0.5181 Remote Similarity NPC609211
0.5181 Remote Similarity NPC610665
0.5135 Remote Similarity NPC178054
0.5062 Remote Similarity NPC165483

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC20050 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5735 Remote Similarity NPD1612 Clinical (unspecified phase)
0.5735 Remote Similarity NPD1613 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data